STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
Management ChangeApr 27, 2026, 04:17 PM

CDT Appoints Ulrik Olsen to Board; Freda Lewis-Hall Resigns

AI Summary

CDT Equity Inc. announced the appointment of Ulrik Olsen as an independent director to its Board, effective April 27, 2026. Mr. Olsen will join the Audit, Compensation, and Nominating and Corporate Governance Committees. Concurrently, Freda Lewis-Hall resigned from the Board due to family health reasons, leading to Chele Chiavacci Farley's appointment as chairperson of the Board and Nominating and Corporate Governance Committee, and Simon Fry's appointment as chairperson of the Audit Committee.

Key Highlights

  • CDT Equity Inc. appointed Ulrik Olsen as a new independent director to its Board.
  • Mr. Olsen will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees.
  • Mr. Olsen is an experienced executive in the commercial property industry, based in New Zealand.
  • Freda Lewis-Hall resigned from the Board for family health reasons, vacating her role as chairperson of the Board and Nominating and Corporate Governance Committee.
  • Chele Chiavacci Farley was appointed chairperson of the Board and Nominating and Corporate Governance Committee.
  • Simon Fry was appointed chairperson of the Audit Committee, with Ms. Farley remaining a member.
CDT
Biotechnology: Pharmaceutical Preparations
CDT Equity Inc.

Price Impact